New polio vaccines: Two groundbreaking oral polio vaccines (nOPVs) have been created by scientists at UCSF and the UK's National Institute of Biological Standards and Control (NIBSC).
Dr Avinash Hari Narayanan (MBChB), Clinical Lead at London Medical Laboratory, explains that we need stronger efforts worldwide to end HIV transmission and improve the lives of those living with the disease.
An urban gardening program has received $3.4 million to reduce food insecurity in the Dominican Republic – and was also found to greatly improve HIV outcomes.
The number of people contracting autoimmune diorders in the United Kingdom is growing, including diseases like type 1 diabetes and rheumatoid arthritis. But why?
Prof. Hartmut J. Ehrlich, MD, CEO of Abivax, explains why the Company’s drug candidate, obefazimod, has the potential to treat Inflammatory Bowel Diseases.
Dr. Ludivine Herman, Project Leader at immunotherapy specialist Imcyse, walks us through Neuoromyelitis optica facts & trends, the challenges of current therapies and the potential of immunotherapies.
Ruplekha Choudhurie, Senior Industry Analyst/Team Lead, walks us through nanomedicine, explaining a multipronged approach to tackle infectious diseases.
Personalised medicine has become essential in practically every field of healthcare, but tailored medicine is extremely vital when it comes to organ transplantation.
